Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01112449 · ClinicalTrials.gov registry record · NA
Influence of Selenium on Prostate Cancer Related Biomarkers
A NA study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 130
- Enrollment target
NCT01112449 is a NA study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 130 participants.
The verdict
NCT01112449, a NA study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
Study Summary
Penn State Milton S. Hershey Medical Center researchers are trying to compare the effects of two different forms of selenium (selenium yeast and selenomethionine) on blood selenium levels and biomarkers of oxidative stress as primary endpoints. One in six men are at risk of getting prostate cancer in their lifetime. Participants will be asked to take over-the-counter selenium yeast supplements and selenomethionine or a placebo for nine out of twelve months.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT selenomethionine
- DIETARY_SUPPLEMENT low dose selenized-yeast
- DIETARY_SUPPLEMENT high dose selenized-yeast
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2008-05 |
| Est. Completion | 2014-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01112449
The ClinicalTrials.gov registry entry for NCT01112449 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT01112449 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01112449 about?
NCT01112449 is a clinical study titled "Influence of Selenium on Prostate Cancer Related Biomarkers". Penn State Milton S. Hershey Medical Center researchers are trying to compare the effects of two different forms of selenium (selenium yeast and selenomethionine) on blood selenium levels and biomarkers of oxidative stress as primary endpoints. One in six men are at risk of getting prostate cancer i...
What is the current status of trial NCT01112449?
This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2008-05. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01112449?
The interventions under investigation include: Placebo (OTHER), selenomethionine (DIETARY_SUPPLEMENT), low dose selenized-yeast (DIETARY_SUPPLEMENT), high dose selenized-yeast (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01112449?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.